购物车
- 全部删除
- 您的购物车当前为空
Elezanumab(ABT-555) 是一种有效的人抗 RGMa 单克隆抗体。Elezanumab 通过 SMAD1/5/8 通路发挥对 RGMa 介导的 BMP 信号传导的抑制作用,IC50 约为 97 pM。在神经元损伤和脱髓鞘模型中,Elezanumab 促进神经再生、神经保护和神经恢复。Elezanumab 促进皮质脊髓轴突生长为脊髓灰质,并增强腹角的血清素能神经支配,形成颈部病变尾部的突触连接。
为众多的药物研发团队赋能,
让新药发现更简单!
Elezanumab(ABT-555) 是一种有效的人抗 RGMa 单克隆抗体。Elezanumab 通过 SMAD1/5/8 通路发挥对 RGMa 介导的 BMP 信号传导的抑制作用,IC50 约为 97 pM。在神经元损伤和脱髓鞘模型中,Elezanumab 促进神经再生、神经保护和神经恢复。Elezanumab 促进皮质脊髓轴突生长为脊髓灰质,并增强腹角的血清素能神经支配,形成颈部病变尾部的突触连接。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,990 | 现货 | |
5 mg | ¥ 4,970 | 现货 | |
10 mg | ¥ 6,880 | 现货 | |
25 mg | ¥ 9,870 | 现货 | |
50 mg | ¥ 13,700 | 现货 |
产品描述 | Elezanumab(ABT-555) is a potent human anti-RGMa monoclonal antibody.Elezanumab exerts its inhibitory effect on RGMa-mediated BMP signaling through the SMAD1/5/8 pathway, with an IC50 of approximately 97 pM.Elezanumab promotes neuroregeneration, neuroprotection, and neural restoration in models of neuronal injury and demyelination. Elezanumab promotes the growth of corticospinal axons into spinal gray matter and enhances serotonergic innervation in the ventral horn, forming synaptic connections in the caudal part of cervical lesions. |
体内活性 | Elezanumab(1-10 mg/kg;静脉注射;每周一次;共5次)在雌性Lewis大鼠的视神经挤压和视神经炎模型中促进轴突再生并防止视网膜神经纤维层退化。[1] Elezanumab(0.01、0.1、1、10 mg/kg;静脉注射;每周一次;共3次)在针对脊髓的雌性Lewis大鼠实验性自身免疫性脑炎(EAE)模型中促进轴突再生和髓鞘再生,减少炎症病灶面积并改善功能恢复。[1] |
别名 | 依来努单抗, AE12-1Y-QL, ABT-555 |
分子量 | 143.43 kDa |
CAS No. | 1791416-49-3 |
存储 | store at low temperature | store at -20°C | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容